Prot# RNA003142-204: Comparison of Weight-Based Doses of Taribavirin Combined with Peginterferon Alfa-2b vs. Ribavirin Combined with Peginterferon Alfa-2b in Therapy-naïve Patients with Chronic Hepatitis C Virus Genotype 1 Infection

Project: Research project

Project Details

StatusFinished
Effective start/end date8/15/078/15/10

Funding

  • PPD Development (RNA003142-204)
  • Valeant Pharmaceuticals International, Inc. (RNA003142-204)